✦ LIBER ✦

Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study

✍ Scribed by Nugent, Diane

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

732 EFFICACY AND TOLERANCE OF TENOFOVIR

✍ M. Levrero; L. Cimino; P. Lampertico; M. Vigano; G.B. Gaeta; G. Brancaccio; E. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Alteplase for the Treatment of Central V

✍ Blaney, Martha; Shen, Violet; Kerner, John A.; Jacobs, Brian R.; Gray, Sarah; Ar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The efficacy and safety of infliximab in

✍ Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; So 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 430 KB

C1 Esterase Inhibitor (C1-INH) Concentra

✍ Goodman, S.; Levy, R.; Wasserman, R.; Bewtra, A.; Hurewitz, D.; Moy, J.; Yang, W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

C1 esterase inhibitor (C1-INH) - Standar

✍ CRAIG, T; WASSERMANN, R; LEVY, R; BEWTRA, A; HUREWITZ, D; PETERS, C; KIESSLING, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

C1 Esterase Inhibitor Concentrate (C1-IN

✍ Levy, R.L.; Wasserman, R.L.; Bewtra, A.K.; Hurewitz, D.H.; Moy, J.N.; Yang, W.H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB